HopeStage
Back to all studies
TerminatedNCT03608137

Cannabis and Thought Disorder in Schizophrenia

Interventional studyAges 18–65France
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 7, 2018
Recruitment status
Terminated
Enrollment listed in the registry
63
Sponsor
Hôpital le Vinatier
Sponsor type
Hospital / academic medical center
Study type
Other
Intervention type
OTHER
Study phase
Not clearly listed
Locations
France
Age range
From 18 Years to 65 Years
Official registry ID
NCT03608137
Official title
Show the full official title

Cannabis and Thought Disorder in Schizophrenia: Clinical and Neuroimaging Relationships

Recruitment & locations

Terminated

Bron

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Hôpital le Vinatier, a hospital or academic medical center.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies